Koru is open to strategic and mutually beneficial, collaborative partnerships

  • Discovery Platform partnerships
  • Asset development partnerships
  • Internal pipeline collaborations
    • Co-development of existing development programs
  • Commercialization and licensing-out
    • Koru works with commercial partners for commercialisation in order to maximise value for our patients.
  • In-licensing:
    • We partner with organisations to in-license compounds at any stage where we have identified new indications

Who do we partner with

  • Life Science Entrepreneurs
  • Spin-out Companies
  • Non-profit organisations
  • Academic institutions
  • Pharmaceutical leaders